Enjoy complimentary customisation on priority with our Enterprise License!
The preeclampsia laboratory testing market is estimated to grow by USD 855.3 million at a CAGR of 8.09% between 2023 and 2028. Market growth is influenced by several factors, including the expansion of markets in emerging economies, the rising occurrence of preterm births, and the increasing number of gynecology clinics. These factors collectively contribute to the growth of the market, highlighting its importance in addressing maternal and child health issues. As the market expands into new regions and addresses the needs of more patients, stakeholders are expected to invest in innovative solutions and healthcare infrastructure to meet growing demands. This trend underscores the significance of the market in improving healthcare outcomes and highlights the need for continued advancements to address the evolving healthcare landscape and demographic trends. It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2018 to 2022.
To learn more about this report, Download Report Sample
The market share growth by the consumables segment will be significant during the forecast period. Consumables are necessary for the selection and enrichment of preeclampsia laboratory testing procedures. Reagents are chemical substances or mixtures that are used during preeclampsia laboratory procedures. Factors such as the low cost and high usage frequency of consumables are driving the growth of the consumables segment.
Get a glance at the market contribution of various segments Request a PDF Sample
The consumables segment was valued at USD 921.20 million in 2018. The consumables segment is likely to grow at a rapid pace during the forecast period. Many suppliers are investing in reagents and consumables, as they generate a high return on investment (ROI). Many government organizations, such as the National Institute of Health (NIH), offer grants for the quarterly reimbursements of R&D of consumables. Therefore, the use of reagents and consumables will increase due to the rise in the number of point-of-care testing in hospitals, clinics, and homes and the growth of online purchases. Hence, such factors are fuelling the growth of the segment during the forecast period.
For more insights on the market share of various regions Request PDF Sample now!
Europe is estimated to contribute 35% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. Preeclampsia, a pregnancy complication characterized by hypertension and proteinuria, necessitates timely diagnosis and medical intervention to prevent severe health consequences for both mother and baby. Hospitalizations due to preeclampsia have increased, underscoring the importance of accurate and early diagnosis. Diagnostic laboratories play a crucial role in identifying preeclampsia through various tests, primarily blood tests. Disease pathogenesis research reveals that low levels of aspirin and calcium in the mother's body may contribute to the condition. As such, blood tests for aspirin metabolites and calcium levels are essential in diagnosing preeclampsia. Medical interventions, including aspirin dose adjustments and calcium supplements, can help manage the disease and reduce the risk of complications. Hence, such factors are driving the market in Europe during the forecast period.
The market plays a crucial role in maternal health, focusing on Preeclampsia Diagnostics to reduce maternal and infant mortality rates. Factors such as Teenage pregnancy rates and the need for Personalized medicinal products drive the demand for accurate POC products and Laboratory tests. Effective Disease management relies on early detection and monitoring, ensuring Patient satisfaction and treatment adherence. Tests assessing Blood pressure, Liver, and Kidney function are vital for identifying organ dysfunction. Antenatal care is enhanced by novel technologies, improving Population health and safety. Diagnostic centers rely on quality Raw materials to deliver accurate results, aiding in the diagnosis of High blood pressure and lifestyle disorders. The integration of Medical technologies enables efficient Clinical and biochemical tests, facilitating early detection and management of preeclampsia. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Public and private insurers do not reimburse for preeclampsia laboratory testing.
Pregnant women are eligible for Medicaid but can lose coverage at sixty days postpartum, which makes them unable to afford preeclampsia laboratory testing.
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbott Laboratories - The company offers preeclampsia laboratory testing such as i-STAT TOTAL beta-hCG CARTRIDGE.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.
You may also interested in below market reports:
The market is crucial in reducing maternal and neonatal mortality rates by improving access to healthcare and raising awareness of preeclampsia among Women in reproductive age. Patient advocacy groups play a key role in promoting early detection through regular Blood tests and advocating for precision medicine approaches. Health insurance policies that cover preeclampsia testing and treatment can reduce financial barriers to care. Diagnostic centers and laboratories play a pivotal role in developing biomarkers for early detection and monitoring disease pathogenesis, leading to timely medical interventions and potentially reducing the need for hospitalization. The use of Calcium supplements and appropriate Aspirin doses are also part of the strategy to manage Pregnancy Hypertension effectively. Increasing access to healthcare includes ensuring that diagnostic centers and diagnostic laboratories have the necessary resources for medical interventions, such as determining the appropriate aspirin dose for patients with kidney issues.
Market Scope |
|
Report Coverage |
Details |
Page number |
172 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.09% |
Market growth 2024-2028 |
USD 855.3 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
7.32 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
Europe at 35% |
Key countries |
US, Germany, China, UK, and India |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, ACON Laboratories Inc., Avecon Healthcare Pvt. Ltd., Bio Rad Laboratories Inc., BioCheck Inc., bioMerieux SA, Biora Therapeutics Inc., Cardinal Health Inc., Diabetomics Inc., F. Hoffmann La Roche Ltd., GestVision Inc., Lifeassay Diagnostics Pty Ltd., MedGyn Products Inc., Metabolomic Diagnostics, MOMM Diagnostics, Perkin Elmer Inc., Quidelortho Corp., Sera Prognostics Inc., Siemens AG, and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market analysis, Market forecasting, market forecast, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, Market growth and Forecasting, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product Type
7 Market Segmentation by Test
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.